Found: 6
Select item for more details and to access through your institution.
Releasing the brakes in coagulation Factor IXa by co-operative maturation of the substrate-binding site.
- Published in:
- Biochemical Journal, 2016, v. 473, n. 15, p. 2395, doi. 10.1042/BCJ20160336
- By:
- Publication type:
- Article
Subcutaneous Marzeptacog Alfa (Activated) for On‐Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 498, doi. 10.1002/cpt.3172
- By:
- Publication type:
- Article
Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 7, p. 977, doi. 10.1002/psp4.12967
- By:
- Publication type:
- Article
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1628, doi. 10.1002/psp4.12872
- By:
- Publication type:
- Article
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3739, doi. 10.1007/s12325-023-02570-6
- By:
- Publication type:
- Article
Enthalpy measurement using calorimetry shows a significant difference in potential energy between the active and latent conformations of PAI-1.
- Published in:
- Biological Chemistry, 2005, v. 386, n. 2, p. 111, doi. 10.1515/BC.2005.014
- By:
- Publication type:
- Article